Financial Provisions. 7.1 You are responsible for: (a) the setup of the Merchant Account with the Merchant Acquiring Bank and the bank’s processor; and (b) any and all set up and Bank Charges and other charges associated with the Merchant Account.
Financial Provisions. Any cooperative activities envisaged or undertaken under this Agreement shall be subject to the availability of resources and to the laws, regulations and policies of the Parties. Costs of cooperative activities shall be borne in such manner as may be mutually determined from time to time between the Parties.
Financial Provisions. 6.1. Maximum CMHC Funding for the HB by relevant Fiscal Year is set out below: Fiscal Year CMHC Funding 2020-2021 $3,839,827 2021-2022 $2,697,589 2022-2023 $8,734,184 2023-2024 $8,330,600 2024-2025 $9,603,400
Financial Provisions. 1. Prices shall be expressed in euro (€) and shall not be affected by any changes in the rate of the euro against other currencies. Prices shall be fixed and not subject to revision for the first year of performance of the contract. Prices shall not vary according to the amount of services requested.
Financial Provisions. III. 8 – Eligible costs of the project Costs may be charged to the grant agreement provided that they comply with the provisions set forth in Part B of Xxxxx XX. In particular, costs related to the initial training activities carried out under the project may be reimbursed by the REA as follows:
Financial Provisions. Article 18
Financial Provisions. 8.1 The maximum CMHC Funding under this Agreement is $23.400 million. This maximum CMHC Funding is available by Fiscal Year in the following amounts: 2011 – 2012: $7.800 million; 2012 – 2013: $7.800 million; 2013 – 2014: $7.800 million. CMHC Funding cannot be reallocated among Fiscal Years without prior CMHC approval. At least $0.080 million in CMHC Funding must be claimed in each Fiscal Year and used under this Agreement for victims of family violence.
Financial Provisions. 1. In consideration of the services performed under this agreement, the Agency shall pay to the contractor a sum of up to a maximum of EURO [Amount in figures] ([Amount in words] …………………) (VAT Excluded) covering all expenses incurred in the course of execution of this agreement, including all travel expenses.
Financial Provisions. The Sponsor (through CRO, if applicable) will provide funding in support of the Clinical Trial, as set out in Annex 3. All payments shall occur on the conditions as set out in this Annex 3. In the event that amendments to the Protocol require changes to the Clinical Trial financing arrangements, an amended financial schedule will be agreed upon and signed by the Parties which will replace the existing Annex 3. If the Agreement is terminated for one of the reasons in clauses 12.2, 12.3 or 12.5, except for material breach by the Institution and/or the Principal Investigator under clause 12.2 (f), and subject to an obligation on the Institution and the Principal Investigator to mitigate any loss, the Sponsor (through CRO, if applicable) shall pay all fees and expenditures falling due for payment to the Principal Investigator and/or the Institution up to the date of termination in accordance with Annex 3, and also all expenditure falling due for payment after the date of termination which arises from uncancellable commitments reasonably and necessarily incurred by the Principal Investigator and/or Institution for the performance of the Clinical Trial prior to the date of termination, in accordance with Annex 3. In the case of termination for material breach by the Institution and/or the Principal Investigator under clause 12.2 (f), and subject to an obligation on the Institution and the Principal Investigator to mitigate any loss, Sponsor (through CRO, if applicable) shall pay all fees and expenditures falling due for payment of properly performed services up to the date of the material breach by the Institution and/or the Principal Investigator in accordance with Annex 3. In case of termination for fraud, bribery or corruption, Sponsor will not pay for fees and expenditures directly related to such fraud, bribery or corruption. In the event of early termination, if payment has been made by the Sponsor (through CRO if applicable) to the Institution or the Principal Investigator in advance for work not completed in accordance with Article 13.3, the Institution and/or the Principal Investigator shall issue a credit note and repay the remainder of the monies within 45 days of receipt of written notice from the Sponsor and/or CRO
Financial Provisions. Article 9
